Cystic Fibrosis lung disease in children. Cystic fibrosis
Conditions
Interventions
Intervention 1: Control group: Patients will receive airway clearance therapies( Hypertonic Saline, Inhaled shortacting beta-2 agonist, azithromycin) and 300 milliliter of cow milk per day as a placeb
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to No maximum
Inclusion criteria
Inclusion criteria: Over 6 year’s children with Cystic Fibrosis lung disease undergoing airway Clearance Treatment The patient is not in the acute exacerbation phase of the disease The patient has completed the Informed consent Form Those who have FEV1 more than 60% in spirometry
Exclusion criteria
Exclusion criteria: Those who are allergic to cow's milk Those who have a severe cough and sputum Those who are hospitalized Those who do not cooperate properly in spirometry
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients with Expiratory Volume in First Second (FEV1) greater than 60%. Timepoint: At the beginning of the study (before the intervention) and two months after beginning milk use (after the intervention). Method of measurement: spirometer device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patient whose Forced Expiratory Volume in First Second (FEV1) increase 10%. Timepoint: At the beginning of the study (before the intervention) and two months after beginning milk use (after the intervention). Method of measurement: spirometer device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Seyed Javad Sayedi
Mashhad University of Medical Sciences
Outcome results
None listed